Journal Information
Vol. 30. Issue 9.
Pages 727-729 (September 2011)
Share
Share
Download PDF
More article options
Vol. 30. Issue 9.
Pages 727-729 (September 2011)
Caso Clínico
Open Access
Arterial thrombosis and acute myocardial infarction with angiographically normal coronary arteries in a woman heterozygous for both factor V Leiden and prothrombin mutation
Trombose arterial e infarto agudo do miocárdio com artérias coronárias angiograficamente normais em mulher heterozigota para fator V de Leiden e mutação do gene da protrombina
Visits
9604
João Gaspara, Cláudio Benchimolb, Telma Gadelhac, Guilherme Loures Pennad,
Corresponding author
guipenna@terra.com.br

Corresponding author:.
a Internal Medicine, Hospital de Ipanema, Hospital Samaritano, Rio de Janeiro, Brazil
b Cardiology Service, Federal University of Rio de Janeiro, Hospital Samaritano, Rio de Janeiro, Brazil
c Hematology Service, Federal University of Rio de Janeiro, Hospital Samaritano, Rio de Janeiro, Brazil
d Internal Medicine, Casa de Saúde São Jose, Hospital Samaritano, Rio de Janeiro, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract

Thirteen years after her last thrombotic event, anticoagulation was discontinued in a patient with combined thrombophilia involving mutation in factor V and G20210A polymorphism of the prothrombin gene. The only history was of arterial thrombosis. Three months later she presented a transmural myocardial infarction caused by coronary thrombosis.

Keywords:
Arterial thrombosis
Myocardial infarction
Thrombophilia
Resumo

Após treze anos do último evento trombótico, a anticoagulação foi interrompida numa paciente com associação de trombofilia factor V de Leiden e gene mutante da protrombina G20210A. Ela possuía história de tromboses arteriais. Três meses após, a paciente apresentou enfarte transmural do miocárdio devido à trombose coronariana.

Palavras-chave:
Trombose arterial
Enfarte do miocárdio
Trombofilia
Full text is only aviable in PDF
References
[1.]
F.R. Rosendaal, D.S. Siscovick, S.M. Schwartz, et al.
Factor V Leiden (Resistance to Activated Protein C) increases the risk of myocardial infarction in young women.
Blood, 89 (1997), pp. 2817-2821
[2.]
F.R. Rosendaal, D.S. Siscovick, S.M. Schwartz, et al.
A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.
Blood, 90 (1997), pp. 1747-1750
[3.]
M. Sharifi, T.G. Frohlich, I.M. Silverman.
Myocardial infarction with angiographically normal coronary arteries.
Chest, 107 (1995), pp. 36-40
[4.]
J.S. Alpert.
Myocardial infarction with angiographically normal coronary arteries.
Arch Intern Med, 154 (1994), pp. 265-269
[5.]
Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group.
No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.
Circulation, 107 (2003), pp. 1117-1122
[6.]
K. Jul, A. Tybjaerg-Hansen, R. Steffensen, et al.
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses.
[7.]
N.S. Van de Water, J.K. French, M. Lund, et al.
Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction.
J Am Coll Cardiol, 36 (2000), pp. 717-722
[8.]
J. Mansourati, A. Da Costa, S. Munier, et al.
Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography.
Thromb Haemost, 83 (2000), pp. 822-825
[9.]
B.P.C. Koeleman, P.H. Reitsma, R.M. Bertina.
Familial thrombophilia: A complex genetic disorder.
Semin Hematol, 34 (1997), pp. 256-264
[10.]
J. Emmerich, F.R. Rosendaal, M. Cattaneo, et al.
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism.
Thromb Haemost, 86 (2001), pp. 809-816
Copyright © 2011. Sociedade Portuguesa de Cardiologia
Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.